GRV STRATEGIES LLC

Lobbying for ELI LILLY AND COMPANY · Biopharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Indiana · House · Senate · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Trade (domestic/foreign)

Issues related to trade

Health Issues

Issues related to healthcare

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem